Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Pfizer is warning that an antibiotic used to treat syphilis and other bacterial infections in young people are likely to run out by the end of this quarter.
Be Well: Alex Rodriguez on the Importance of Dental Hygiene Following Gum Disease Diagnosis
Be Well: Key Stretches to Consider Before Your Workout
A scientist at the University of California, Riverside is designing an emoji-based measurement system to aid communication between patients and doctors, arguing they could be particularly useful for patients who cannot speak.
Thousands of dead fish washed up ashore in southwest Texas.
Only 1 in 4 residential treatment centers for teens offers a recommended medicine for opioid addiction, according to a study that exposes an important gap in care.
Be Well: Understanding Infertility and Weighing Options to Start a Family
Be Well: Building Strength, Cardio and Mindfulness at 'The Class'
The NASA Artemis 3 mission in 2025 plans to investigate whether microorganisms may have survived in the moon's permanently shadowed craters .
According to NASA, a "potentially dangerous" asteroid about the size of a bridge narrowly passed Earth on Monday.
